Hutch News

Hutch News

Stories tagged 'George McDonald'

Common genetic disorder linked to increased death rate from cancer drug

Researchers recommend ‘caution’ when using the chemotherapy busulfan in patients with Gilbert’s syndrome

Oct. 27, 2016 | By Susan Keown / Fred Hutch News Service

As many as one of every 10 people has Gilbert's syndrome, which is typically benign and has even been linked to long life. But new research suggests that busulfan, a bone marrow transplant drug, is extra risky in people with the condition.

View story >

Cannabis and cancer: More patients going public with pot passions and practices

But some doctors voice concerns about safety, risks of Rx weed

July 17, 2015 | By Bill Briggs / Fred Hutch News Service

More cancer patients and survivors seem to be asking doctors about medical marijuana - or opening up about using cannabis to ease effects of the disease and its treatments.

View story >

'Got my life back': Bone marrow transplant shows promise as Crohn's disease cure

New trial, old love fueling one woman's rejuvenation

July 8, 2015 | By Bill Briggs / Fred Hutch News Service

One year after receiving a bone marrow transplant to treat her severe Crohn's disease, Elise Elholm is eating new foods, enjoying new energy and feeling well or the first time in decades.

View story >

Al-Johani Award will support new transplant protocol for Crohn's disease

Fred Hutchinson Cancer Research Center clinical investigator George McDonald will use the prize to 'pay it forward' by studying a new treatment approach for an incurable disease

April 29, 2013 | By Galen Motin Goff

View story >

Crohn's disease: New trial tests transplantation for cure

Fred Hutchinson Cancer Research Center study represents new use of bone marrow transplantation

July 23, 2012 | By Dean Forbes

View story >

Transplantation refinements boost long-term survival of blood cancers

Clinical Research Division study shows 41 percent drop in post-transplant deaths compared to mid-1990s

Nov. 29, 2010 | By Dean Forbes

Refinements over the last 10 years in marrow and stem cell transplantation to treat blood cancers significantly reduced the risk of treatment-related complications and death, according to an institutional self-analysis of transplant-patient outcomes conducted at the Fred Hutchinson Cancer Research Center.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.